Skip to main content
Fig. 2 | Diagnostic Pathology

Fig. 2

From: Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma

Fig. 2

Characterization of the stable expression level of CLDN17. a Detection of CLDN17 in the HL7702 cell line by real-time PCR; (b) Detection of CLDN17 expression in the HL7702 cell line by western blotting; (c) Detection of CLDN17 expression in the HL7702 cell line by immunofluorescence; (d) The corresponding statistical analysis of protein expression in the HL7702 cell line. Note: * represents P < 0.05, and ** represents P < 0.01 compared with the empty vector groups

Back to article page